News

The past decade has seen a compounding surge in the use of medical cannabis, with patient registries swelling and dispensaries multiplying at a velocity few policymakers anticipated. As the landscape shifts, one concern consistently rises to the top: public safety. It’s a scenario that’s becoming more and more common—legislators, community leaders, and families triage news […]

Medical cannabis programs have exploded across the United States, with 38 states and the District of Columbia now offering some form of legal medical access as of 2024. But as this sector gains velocity, the regulatory terrain has become a patchwork of policies, each attempting to triage competing priorities: patient safety, product quality, access, and […]

Montana’s legalization of medical marijuana was not a quiet evolution. It arrived amid national debates, shifting federal priorities, and compounding legal uncertainty for patients and providers alike. Today, thousands of Montanans benefit from access to cannabis for qualifying medical conditions. But in many cases, the velocity of legal change outpaces public understanding—leaving patients and caregivers […]

The acceleration of medical marijuana’s popularity is impossible to ignore. Over the last decade, legislative shifts, patient advocacy, and mounting anecdotal evidence have amalgamated to drive demand—and with it, a compounding need for rigorous, science-driven guidance. For patients seeking alternatives to conventional therapies, the promise is alluring. But in many cases, the operational reality is […]

Medical cannabis is now legal in 38 states, a velocity that would have seemed unthinkable even a decade ago. But in many cases, the compounding effect of state-by-state legalization has produced a regulatory patchwork so complex that even experienced providers and patients find themselves navigating a maze of eligibility, access, and compliance. This is what […]

Montana’s medical cannabis program was introduced with a clear intention: to provide seriously ill residents with a safe, regulated alternative for symptom relief and improved quality of life. Policymakers envisioned a tightly governed system—one that would protect patients, ensure product safety, and prevent diversion. But in many cases, the reality for Montanans living with chronic […]

Montana’s medical marijuana policy landscape has evolved with a velocity that outpaces most healthcare regulatory reforms. In 2011, the passage of IR-124 marked a pivot point, introducing a suite of restrictions that rippled through clinical practice and patient experience. For healthcare professionals, these changes have compounded operational friction—forcing a triage of priorities between compliance, patient […]

Montana’s relationship with medical marijuana has never been static; it’s a case study in legislative whiplash. What began as a voter-driven push for compassionate care has, over the past two decades, become an ongoing negotiation between access, regulation, and political winds. Patient rights—once an afterthought in the velocity of policy-making—have now emerged as the central […]

The modern workplace is constantly evolving, necessitating regular adaptations in policy and practice. One such area of contention and ongoing debate is the issue of marijuana drug testing in the workplace. As jurisdictions across the world begin to legalize the use of marijuana for medicinal and recreational purposes, businesses and regulators alike are grappling with […]

In the ever-evolving landscape of drug policies, one particular substance has been in the limelight: marijuana. As its legalization gains ground globally, this throws a significant curveball at workplace drug testing policies. This article aims to explore the reasons why marijuana could be considered for exclusion from drug testing and discuss potential alternatives. The Purpose […]